Natco Pharma Limited
FDA inspection history in Anakapalli, India, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Anakapalli, India.
Cited most
Across all Natco Pharma Limited observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.192Production record review1
The complete Natco Pharma Limited file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Anakapalli, India
One Form 483 · 2023 · 2 observations
Latest: Form 483, Feb 3, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-02-03 | 483 Form 483 | Anakapalli, India | 2 | $99 |
Investigators on these documents
FEI number 3015380536 · most recent document Feb 3, 2023
About Natco Pharma Limited
How many FDA Form 483s has Natco Pharma Limited received?
FDA Intel has 1 Form 483 on file for Natco Pharma Limited; the most recent is dated Feb 3, 2023.
When was Natco Pharma Limited last inspected by FDA?
The most recent FDA inspection document on file for Natco Pharma Limited is a Form 483 dated Feb 3, 2023, for the site in Anakapalli, India.
What did FDA cite at Natco Pharma Limited?
The regulations cited most in the observations on file for Natco Pharma Limited are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.192 (Production record review), 1 time.